Form 4: AMAL Director Edgar Romney Exercises Options, Sells Shares
Insider Transaction Report
Amalgamated Financial Corp. Director Edgar Romney reported exercising stock options, selling shares, and receiving restricted stock units in late October and early November 2025.
Summary
- Director Edgar Romney exercised non-qualified stock options for a total of 13,000 shares of Common Stock on October 30, 2025, at exercise prices of $12, $13.75, and $14.65.
- Following option exercises, 6,310 shares were disposed of on October 30, 2025, at a price of $27.5575, primarily to cover tax withholding obligations.
- On October 31, 2025, Romney sold 6,697 shares of Common Stock in the open market at a weighted average price of $27.3424, with individual transaction prices ranging from $27.065 to $27.63.
- On November 1, 2025, Romney received a grant of 2,311 restricted stock units (RSUs) which vested immediately upon grant.
- This RSU grant was in consideration of the company's termination of its stock option program and Romney's early exercise of all outstanding and vested stock options on October 30, 2025.
- Romney's direct beneficial ownership of Common Stock increased from 21,590 shares (after initial exercise) to 25,382 shares (after subsequent exercises) before decreasing to 16,763 shares (after sales) and finally settling at 19,074 shares after the RSU grant.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While the director sold a notable number of shares, which can be seen negatively, the transactions also include profitable option exercises and a new grant of immediately vesting restricted stock units, indicating ongoing compensation and equity alignment.
Positives
- Director Edgar Romney received a grant of 2,311 restricted stock units, which vested immediately, indicating continued equity compensation.
- The exercise of stock options at prices significantly below the market sale price (e.g., $12, $13.75, $14.65 vs. $27.3424) indicates a profitable transaction for the insider.
Negatives
- Director Edgar Romney sold a total of 6,697 shares in the open market, which could be interpreted as a reduction in insider exposure to the company's stock.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance.
Management Comments
- The reported transaction involved the reporting person's receipt of a grant of 2,311 restricted stock units, which vested immediately upon grant.
- This RSU grant was in consideration of the company's termination of the stock option program and the Director's early exercise of all outstanding and vested stock options on October 30, 2025.
Industry Context
Insider transaction reports (Form 4s) are routine disclosures for publicly traded companies, providing transparency into stock ownership changes by directors, officers, and significant shareholders. These transactions are typically driven by individual financial planning, compensation structures, or strategic decisions, rather than broader industry trends, though the shift from stock options to RSUs can reflect evolving compensation practices.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy Change | The company terminated its stock option program, replacing it with a grant of restricted stock units for the director. This indicates a shift in the equity compensation strategy for key personnel. | 11/01/2025 | This change could simplify equity compensation administration and potentially align director incentives more directly with stock price performance, as RSUs typically have less downside risk for recipients compared to options. |
Stakeholder Impact
- Shareholders: The sale of shares by a director could be viewed with caution, potentially signaling a lack of confidence, although it could also be for personal financial planning. The RSU grant maintains director equity alignment.
- Employees: The termination of the stock option program for directors might indicate a broader shift in equity compensation strategy that could eventually affect other employees.
Key Dates
| Date | Description |
|---|---|
| 01/01/2016 | Date exercisable for a portion of non-qualified stock options. |
| 01/01/2017 | Date exercisable for a portion of non-qualified stock options. |
| 01/01/2018 | Date exercisable for a portion of non-qualified stock options. |
| 10/30/2025 | Date of option exercises, tax-related dispositions, and early exercise of all outstanding and vested stock options. |
| 10/31/2025 | Date of open market sale of common stock. |
| 11/01/2025 | Date of restricted stock unit grant. |
| 01/01/2026 | Expiration date for a portion of non-qualified stock options. |
| 01/01/2027 | Expiration date for a portion of non-qualified stock options. |
| 01/01/2028 | Expiration date for a portion of non-qualified stock options. |
| 11/03/2025 | Signature date of the reporting person for the Form 4 filing. |
Keywords
Amalgamated Financial Corp, AMAL, Edgar Romney, Insider Transaction, Form 4, Stock Options, Restricted Stock Units, Share Sale, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.